We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Simulator Trains Surgeons in Holmium Laser Enucleation of the Prostate

By HospiMedica International staff writers
Posted on 07 May 2009
A computer-guided interactive Holmium Laser Enucleation of the Prostate (HoLEP) training simulator allows more physicians to be trained on the procedure.

The HoLEP surgical training simulator works by displaying haptically and graphically deformable virtual prostates to the surgeons, using computer-based three-dimensional (3D) modeling procedures. More...
By using the simulator, surgeons can practice HoLEP, based on the Lumenis VersaPulse PowerSuite laser with the VersaCut Morcellator system. HoLEP has been shown to provide superior outcomes and long-term durability in treating benign prostatic hyperplasia (BPH) of all gland sizes; bladder calculi, if present, are easily vaporized by the holmium laser at the same time. Utilizing this technique, even the largest of glands can be effectively treated with minimal morbidity. However, the learning curve remains an obstacle, preventing more widespread adoption of the technique, which created the demand for a training simulator. The Lumenis VersaPulse PowerSuite laser, the VersaCut Morcellator system, and the HoLEP training simulator are all products of Lumenis (Yokneam, Israel).

"The HoLEP simulator is the future of surgical training,” said James Lingeman, M.D., a clinical professor of urology at Indiana University School of Medicine (Indianapolis, USA). "This learning approach allows physicians to practice the procedure and first achieve a standard level of competence before operating live. This new training technology will benefit physicians and patients alike.”

"The clinical data supporting the superiority of the HoLEP procedure is significant,” said Dov Ofer, CEO of Lumenis. "Lumenis is committed to providing the state-of-the-art training tools so that more urologists can become proficient with the HoLEP procedure and make it available to patients worldwide.”

Holmium lasers are ideal for precisely and cleanly ablating without charring or overheating tissue, since the holmium absorption depth is only 0.5 mm or less. This causes the tissue to be ablated rapidly, before it can conduct heat, which minimizes thermal damage to the surrounding healthy tissue. Additionally, the localized coagulation effect of the holmium laser "seals” the tissue and provides hemostasis and fluid absorption that have been found to be superior to electrocauterization.

Related Links:

Lumenis




Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
VTE Prevention System
Flowtron ACS900
Endoscopy Display
E190
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.